相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Podocyte-specific Crb2 knockout mice develop focal segmental glomerulosclerosis
Akiko Tanoue et al.
SCIENTIFIC REPORTS (2021)
Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression
Mona K. Tawfik et al.
MOLECULAR BIOLOGY REPORTS (2021)
Roles of Sodium-Glucose Cotransporter 2 of Mesangial Cells in Diabetic Kidney Disease
Masanori Wakisaka et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Special Issue Diabetic Nephropathy: Diagnosis, Prevention and Treatment
Marta Ruiz-Ortega et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy
Lili Zhang et al.
JOURNAL OF DIABETES RESEARCH (2020)
Telmisartan alleviates collagen type III glomerulopathy: A case report with literature review
Qiaoyan Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
Muluken Altaye Ayza et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE - EXECUTIVE SUMMARY
Adrian Liew et al.
NEPHROLOGY (2020)
Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial
Mitsuhide Naruse et al.
PLOS ONE (2019)
Glomerular podocytes in diabetic renal disease
Pawel Podgorski et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2019)
Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy
Rong-Mei Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Hans-Joachim Anders et al.
NATURE REVIEWS NEPHROLOGY (2018)
Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China
Jin-Hua Hou et al.
KIDNEY DISEASES (2018)
Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis
Nektaria Papadopoulou-Marketou et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Saxagliptin Attenuates Albuminuria by Inhibiting Podocyte Epithelial-to-Mesenchymal Transition via SDF-1α in Diabetic Nephropathy
Yun-peng Chang et al.
FRONTIERS IN PHARMACOLOGY (2017)
Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy
Wilhelm Kriz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis
Salma Malik et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Benazepril affects integrin-linked kinase and smooth muscle α-actin expression in diabetic rat glomerulus and cultured mesangial cells
Honglin Niu et al.
BMC NEPHROLOGY (2014)
Inhibition of Src Kinase Blocks High Glucose-Induced EGFR Transactivation and Collagen Synthesis in Mesangial Cells and Prevents Diabetic Nephropathy in Mice
Kanta Taniguchi et al.
DIABETES (2013)
Telmisartan inhibits AGE-induced podocyte damage and detachment
Kei Fukami et al.
MICROVASCULAR RESEARCH (2013)
Fenofibrate Attenuated Glucose-Induced Mesangial Cells Proliferation and Extracellular Matrix Synthesis via PI3K/AKT and ERK1/2
Rui Zeng et al.
PLOS ONE (2013)
Telmisartan Exerts Renoprotective Actions via Peroxisome Proliferator-Activated Receptor-γ/Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1 Receptor Blockade
Hiroshi Kusunoki et al.
HYPERTENSION (2012)
Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease
Akihiro Fukuda et al.
KIDNEY INTERNATIONAL (2012)
Telmisartan in the Management of Diabetic Nephropathy: A Contemporary View
Pitchai Balakumar et al.
CURRENT DIABETES REVIEWS (2012)
Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy
Hiroki Fujita et al.
HYPERTENSION RESEARCH (2011)
Telmisartan in incipient and overt diabetic renal disease
Roland E. Schmieder et al.
JOURNAL OF NEPHROLOGY (2011)
Protein kinase C β inhibition ameliorates experimental mesangial proliferative glomerulonephritis
Hirobumi Tokuyama et al.
NEPHROLOGY (2011)
Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis
Luigi Villa et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Renoprotective Effects of Various Angiotensin II Receptor Blockers in Patients with Early-Stage Diabetic Nephropathy
Tsukasa Nakamura et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2010)
Effect of Telmisartan on Renal Outcomes A Randomized Trial
Johannes F. E. Mann et al.
ANNALS OF INTERNAL MEDICINE (2009)
PKC-β1 Mediates Glucose-Induced Akt Activation and TGF-β1 Upregulation in Mesangial Cells
Dongcheng Wu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Telmisartan inhibits methylglyoxal-mediated cell death in human vascular endothelium
Tatsuya Baden et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Increased renal gene transcription of protein kinase C-β in human diabetic nephropathy:: relationship to long-term glycaemic control
R. G. Langham et al.
DIABETOLOGIA (2008)
The telmisartan renoprotective study from incipient nephropathy to overt nephropathy rationale, study design, treatment plan and baseline characteristics of the incipient to overt: Angiotensin II receptor blocker, telmisartan, investigation on type 2 diabetic nephropathy (INNOVATION) study
H Makino et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2005)
Podocyte proliferation and differentiation in glomerular disease: role of cell-cycle regulatory proteins
SV Griffin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis
SI Miura et al.
EMBO JOURNAL (2000)
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice
FN Ziyadeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes
D Koya et al.
FASEB JOURNAL (2000)
分享论文
